Cantargia’s TRIFOUR Phase 2 Study Investigating Nadunolimab in Triple Negative Breast Cancer Fully Recruited

March 10, 2025 10:15 AM

Cantargia (Cantargia AB); (Nasdaq Stockholm:CANTA) today announced that all patients in the TRIFOUR clinical study are recruited. This phase 1b/2 study in advanced triple-negative breast cancer (TNBC) patients focuses on evaluating the efficacy of nadunolimab (CAN04) in combination with platinum-based chemotherapy compared to a control group receiving the same regime of chemotherapy alone. The first preliminary analysis of the primary objective,...

Read more

Flexibility of a Home Dialysis Nurse

March 10, 2025 9:35 AM

At DaVita, we want our teammates to find the right role with flexible shifts to fit their lifestyle so they can grow their career, prioritize their well-being and reach their goals - inside and outside of work. Hear Ansel, Home Hemodialysis Registered Nurse at DaVita, talks about his schedule and the flexibility he has found in his role.About DaVita Inc.DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve...

Read more

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

March 10, 2025 9:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has acquired the rights to two gastrointestinal drugs and already launched one. The second is planned to be launched in the next 9 months.The newly launched drug is Prucalopride, a generic...

Read more

Stemtech Corporation Announces Strategic Leadership Additions and Milestones Toward StemPets(TM) Launch in 2025

March 10, 2025 8:30 AM

Stemtech, the global leader in stem cell nutrition, is proud to announce key strategic appointments and a forward-looking path toward the launch of its highly anticipated StemPets product line. With an unwavering commitment to enhancing the lives of individuals and their pets, Stemtech continues to innovate in the stem cell and wellness space.Launch of StemPets™: A Game Changer in Pet HealthStemtech is on track to launch StemPets in early Q2 of...

Read more

Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis

March 10, 2025 8:15 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced positive topline results from ANTHEM-UC, a Phase 2b study of icotrokinra (JNJ-2113), the first investigational targeted oral peptide that selectively blocks the IL-23 receptor, in adults with moderately to severely active ulcerative colitis (UC). The study conducted by Protagonist's collaboration partner, Johnson & Johnson, met its primary endpoint of clinical...

Read more

Notice to Convene Annual General Meeting 2025

March 10, 2025 8:15 AM

HØRSHOLM, DK / ACCESS Newswire / March 10, 2025 / Gubra (CPH:GUBRA)Notice to convene ANNUAL GENERAL MEETING 2025GUBRA A/SCVR NO. 30 51 40 41To the shareholders of Gubra A/S (CVR no. 30 51 40 41), notice is hereby given of the annual general meeting of Gubra A/S (the "Company") to be held on:THURSDAY, 3 APRIL 2025 AT 10:00 AM (CEST)GUBRA A/SHØRSHOLM KONGEVEJ 11BDK-2970 HØRSHOLMIn accordance with article 12.1 of the articles of association the...

Read more

CTT Pharma Uplists to the OTCQB Today

March 10, 2025 7:15 AM

CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has entered the OTCQB Market today under the ticker symbol "CTTH". CTT Pharma's CEO will issue a news release to shareholders this Wednesday March 12, 2025.About CTT Pharmaceuticals Holdings, Inc.CTT has patented technology in the United States, Europe, Canada and many additional countries to allow many actives on a dissolvable strip that include but are not limited to Nicotine, Vitamins, and...

Read more

Neurodivergent Empowerment Institute (NEI) Launches Superhero Academy: A Play-Based Therapy Program for Neurodivergent Youth

March 10, 2025 6:00 AM

The Neurodivergent Empowerment Institute (NEI), founded by Bionic Bloom, is thrilled to announce the launch of the Superhero Academy, an innovative play-based therapy program designed to help neurodivergent youth build confidence, emotional regulation, and social skills through imaginative and interactive storytelling.The Superhero Academy transforms therapy into an adventure, using role-playing, problem-solving missions, and creative expression...

Read more

Nanomerics Reports Last Volunteer Visit in the OC134 Sunlight Trial; The Sunlight Trial Met Its Primary Endpoints

March 10, 2025 2:00 AM

Nanomerics Ltd., a private speciality pharmaceutical company today announced that it had completed 28 consecutive days of administration in its OC134 Phase I trial - the SUNLIGHT trial and discharged the last volunteer from the trial. The last volunteer, last visit event concludes the clinical part of the trial. Nanomerics is pleased to report that the trial met its primary endpoints. All volunteers (n=10) completed the 28-day consecutive twice...

Read more

Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis

March 8, 2025 9:15 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced new icotrokinra (JNJ-2113) data from the comprehensive Phase 3 clinical program and the planned initiation of the first-ever head-to-head study in plaque psoriasis (PsO) seeking to demonstrate the superiority of an oral pill, icotrokinra, compared to an injectable biologic, ustekinumab. Icotrokinra is a first-in-class investigational targeted oral peptide that...

Read more

Ainos Reports Full Year 2024 Financial Results

March 7, 2025 4:45 PM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQAIMDW) ("Ainos", or the "Company") today announced its financial results for the fiscal year ended December 31, 2024.Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "2024 marked another pivotal year as we transitioned from our COVID-19 antigen rapid test business to advancing the VELDONA® and pioneering AI Nose programs. This shift has positioned us at the...

Read more

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

March 7, 2025 1:30 PM

SAN DIEGO, CA / ACCESS Newswire / March 7, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer of smell digitization, today announced that Water Tower Research ("WTR") has published a report on the Company's strategic partnership with ugo, Inc., a leading Japanese service robotics company. The collaboration will integrate Ainos' innovative AI Nose technology into ugo's service robots, marking a milestone in...

Read more

Shoreline Recovery Center Highlights Important Link Between Relationships and Mental Health

March 7, 2025 1:00 PM

Studies show that people who are more socially connected to family, friends, or their community are typically happier and physically healthier. They therefore live longer, with fewer problems than individuals who are less connected. At Shoreline Recovery Center, the staff understand firsthand this type of destructive consequences, with many employees in recovery themselves.In fact, relationships are one of the most important aspects of our lives...

Read more

San Diego-Based Facility Park Mental Health Provides Tips to Help Individuals Navigate Mental Health Triggers During the Winter Season

March 7, 2025 1:00 PM

During this time of year, most people have put away their poinsettias and disposed of their trees to move onto the coming months. However, remnants of the holiday season linger for others struggling with its effects on their mental health. Park Mental Health is putting an emphasis on providing patients with hope in the new year."The holiday season often comes with high social and familial expectations that can feel overwhelming, particularly for...

Read more

Avel eCare Recognizes the Dedication of Hospitalists and Highlights Telemedicine as a Key Partner in Patient Care

March 7, 2025 9:12 AM

Avel eCare is shining a spotlight on the essential work of hospitalists and their dedication to patient care. These physicians play a crucial role in hospitals, managing inpatient treatment, coordinating with care teams, and ensuring patients receive the attention they need around the clock. But with growing patient loads, staffing shortages, and increasing burnout, hospitalists need more support than ever."Our telemedicine hospitalists don't...

Read more

BIO-Europe Spring 2025: Partnering is Surging - All Roads Lead to Milan for Biopharma’s Premier Springtime Event

March 7, 2025 8:15 AM

EBD Group is excited to welcome the international biopharmaceutical industry to the "must-attend" springtime partnering conference, BIO-Europe Spring®, set to take place March 17-19, 2025, in Milan, Italy.With a 10% increase in total meeting requests, partnering is hitting record levels. The 2025 edition of BIO-Europe Spring in Milan is expected to be a milestone event, bring together over 3,700 international stakeholders - from academia,...

Read more

Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results

March 7, 2025 8:00 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the fourth quarter and full year 2024 ended December 31, 2024 after market close on Thursday, March 20, 2025. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in...

Read more

AI and Interoperability Trends: Black Book's AMIA Membership Survey Highlights Key Challenges and Opportunities in Healthcare IT

March 7, 2025 8:00 AM

A new Black Book Research survey conducted among the 5,000-member base of the American Medical Informatics Association (AMIA) provides critical insights into the current landscape, challenges, and future expectations surrounding AI-driven healthcare innovations and interoperability advancements. The findings illuminate emerging investment priorities, adoption barriers, and opportunities for digital health transformation across a broad spectrum...

Read more

After All Augusta National Masters Tickets Have Been Allocated, Azalea House Hospitality Offers Tickets

March 7, 2025 6:00 AM

Azalea House announced that they still have some 2025 Masters tickets as well as VIP experiences available. This followed Augusta National Golf Club announced that all of the 2025 Masters Tickets have been allocated, so interested parties will not be able to purchase tickets through the golf club.Azalea House offers tickets in multiple packages. Golf enthusiasts can buy masters tickets to the Masters. Alternatively, they can pay for a hotel stay...

Read more

Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results

March 6, 2025 4:05 PM

Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended December 31, 2024 and provided full year revenue guidance for 2025.Fourth Quarter 2024 Financial HighlightsRevenue of $31.5 million, up 12%, compared to the prior year quarterGross margin of 50.8% compared to...

Read more